The studies reveal that neuroinflammation, which is common in AD brains, may act as a mediator for meth-induced APP expression through HMGB1 [99], shedding light on the potential mechanism by which meth exposure causes neurotoxicity and neurological deficits in AD. Here, HMGB1 is linked to Alzheimer disease.